Education
About Us
Working with TipRanks
Follow Us
Bavarian Nordic A/S (BVNRY)
OTHER OTC:BVNRY
Earnings Data
Report Date
Aug 22, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 09, 2025
|% Change Since: 8.95%
|Next Earnings Date:Aug 22, 2025
Earnings Call Sentiment|Positive
Bavarian Nordic's earnings call highlights strong revenue growth and a solid start to the year, driven by impressive performances in travel health and a new U.S. government contract. The successful launch of the Chikungunya vaccine further supports positive prospects. However, there are minor concerns regarding the public preparedness revenue shortfall and potential currency exchange risks. Overall, the positive aspects significantly outweigh the negatives.Company Guidance
During the Bavarian Nordic Q1 2025 earnings call, the company reported a robust start to the fiscal year with almost DKK 1.4 billion in revenue, marking a 62% growth compared to the previous year. The EBITDA margin was strong at 31%. Key contributors to this performance included a solid manufacturing output that enabled the advancement of some public preparedness orders, and a new $144 million order from the U.S. government, boosting revenue for 2026. In the travel health sector, the company experienced significant growth in rabies and TBE vaccine sales, with market share gains in key areas like the U.S. and Germany. Additionally, the launch of the Chikungunya vaccine, VIMKUNYA, in the U.S., Europe, and U.K. contributed to the positive results. Bavarian Nordic maintains a full-year revenue guidance of DKK 5.7 to 6.7 billion and an EBITDA margin of 26% to 30%, despite currency fluctuations and other uncertainties.Strong Revenue Growth
Bavarian Nordic recorded almost DKK1.4 billion in revenue, representing a 62% growth compared to the previous year.
EBITDA Margin Achievement
The company established an EBITDA margin of 31%, indicating a strong start to the year.
Travel Health Sales Surge
Travel health segment showed a 52% growth, driven by rabies and TBE vaccines, with rabies growing by 53% and TBE by 62%.
Chikungunya Vaccine Launch
Bavarian Nordic launched its Chikungunya vaccine, VIMKUNYA, which has been approved in the U.S., Europe, and the U.K., with initial sales recorded.
New Order from U.S. Government
A new order from the U.S. government (BARDA) for $144 million was secured, increasing existing contracts from DKK2.5 billion to DKK2.65 billion.
Gross Margin Improvement
Achieved a gross margin of 51%, two percentage points better than last year's full-year performance.
Future Growth in Travel Health
The travel health market is expected to grow at a 20% CAGR, with Bavarian Nordic well-positioned due to expanding endemic regions and new vaccine introductions.
BVNRY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BVNRY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 09, 2025 | $7.82 | $8.29 | +6.01% |
Mar 05, 2025 | $7.69 | $8.08 | +5.07% |
Nov 15, 2024 | $9.68 | $7.96 | -17.77% |
Aug 22, 2024 | $12.28 | $13.52 | +10.10% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Bavarian Nordic A/S (BVNRY) report earnings?
Bavarian Nordic A/S (BVNRY) is schdueled to report earning on Aug 22, 2025, TBA Not Confirmed.
What is Bavarian Nordic A/S (BVNRY) earnings time?
Bavarian Nordic A/S (BVNRY) earnings time is at Aug 22, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BVNRY EPS forecast?
Currently, no data Available